Oneview Healthcare PLC · ASX:ONE
Oneview Healthcare — Investor Presentation (November 2017)
43 slides from Oneview Healthcare's investor presentation, Nov 17, 2017
Slide 1: Equity Raising Investor Presentation
For personal use only Oneview Healthcare PLC Equity Raising Investor Presentation 17 November 2017
Slide 2: Legal disclaimer
Legal disclaimer For personal use only This presentation has been prepared by Oneview Healthcare PLC (Irish Company Registration - (513842)) (ARBN 610 611 768 ) (Oneview or Company) and is dated 17 November 2017. This presentation contains summary information about Oneview and its subsidiaries (Grou
Slide 3: Legal disclaimer
Legal disclaimer For personal use only See “International Selling Restrictions” in Appendix C of this presentation for restrictions on participation in the Offer by residents in certain other jurisdictions outside of Australia, New Zealand or Ireland. The Underwriter may have interests in the CDIs o
Slide 4: Legal disclaimer
Legal disclaimer For personal use only Financial data This presentation includes certain historical financial information extracted from Oneview’s annual audited consolidated financial statements, Oneview’s reviewed consolidated half year financial statements and certain historical financial informa
Slide 5: Legal disclaimer
Legal disclaimer For personal use only Any forward-looking statements contained in this presentation are provided as a general guide only, they are not guarantees or predictions of future performance and involve known and unknown risks, contingencies and uncertainties and other factors, many of whic
Slide 6: Proving a more engaged patient leads to better clinical outcomes
For personal use only Proving a more engaged patient leads to better clinical outcomes 6
Slide 7: Equity Raising Details
For personal use only Equity Raising Details 7
Slide 8: Overview of equity raising
Overview of equity raising For personal use only Oneview is undertaking an equity raising of approximately A$30 million • An institutional placement to raise approximately A$5 million (Placement); and • A 1 for 4.35 pro-rata accelerated non-renounceable entitlement offer to raise approximately A$25
Slide 9: Entitlement offer overview
Entitlement offer overview For personal use only Offer size and • Equity raising to raise approximately A$30 million (Offer), comprising: structure ― An Institutional Placement to raise approximately A$5 million (Placement); and ― A 1 for 4.35 pro-rata accelerated non-renounceable entitlement offer
Slide 10: Indicative timetable
Indicative timetable For personal use only Event Date1 Trading halt and announcement of Equity Raising, Institutional Entitlement Offer and Placement opens Friday, 17 November 2017 Institutional Entitlement Offer and Placement closes Friday, 17 November 2017 Trading halt lifted – existing CDIs recom
Slide 11: Business update
For personal use only Business update 11
Slide 12: Oneview business update
Oneview business update For personal use only Oneview now addresses multiple end user markets with the deployment of Android commencing in December 2017 • Material growth since IPO - live facilities growing from 9 to 22, total contracted beds +163% from 3,292 to 8,6661 • Successful expansion of tech
Slide 13: Product expansion
Product expansion For personal use only Oneview is significantly expanding its offering to address the continuum of care In-Patient Connect Senior Living Patient Pathways • Core products include Patient • Connect enables healthcare providers to • Extension of in-patient solutions • NHS Hospitals are
Slide 14: Technology enhancement
Technology enhancement For personal use only Oneview’s Android solution is in its initial deployment phase and is expected to accelerate market penetration • Oneview has invested significant resources into the development of an Android solution o The Android solution will materially lower cost of ow
Slide 15: Technology enhancement
Technology enhancement For personal use only Oneview’s Android solution includes a new user interface 15
Slide 16: Oneview patient-facing products and their technologies
Oneview patient-facing products and their technologies For personal use only Sectors Acute & Ambulatory Care Aged Care Our In-Patient Connect Senior Living products • Engaging patients: with education & goals • Highly usable: designed as a consumer app, leveraging • Sales process automation: digitis
Slide 17: Technology enhancement
Technology enhancement For personal use only Recent case studies of customers contracted to benefit from the open Oneview platform on Android • The 7 year contract provides for the further roll-out of Oneview’s • Oneview signed in February 2017, a multi year agreement solution for up to 2,000 device
Slide 18: Market opportunity – In-Patient
Market opportunity – In-Patient For personal use only Oneview has actively identified prospective opportunities to increase market penetration for its In-Patient solution Number of hospital beds United States Australia Medical Tourism4 Total Market ~1 million ~90k ~290k Target Opportunities ~0.3 mil
Slide 19: Market opportunity – In-Patient
Market opportunity – In-Patient For personal use only Of the ~1 million beds in the United States, Oneview has conducted a bottom up sizing of high quality opportunities • Oneview has a targeted approach to identifying Total US Market: ~1 million hospital beds opportunities in the United States Iden
Slide 20: Market opportunity – Senior Living
Market opportunity – Senior Living For personal use only Oneview is expanding its addressable market to Senior Living which is 2.5x to 3x the size of the acute hospital market United States Australia ~2.9 million total beds1 ~0.3 million total beds1 Top 12 operators have ~0.3m beds1 ~10% of populati
Slide 21: Market opportunity – Patient Pathways
Market opportunity – Patient Pathways For personal use only Oneview is expanding its addressable market from its core in-patient offering to adjacent healthcare verticals 62 day waiting target Target opportunity: 1 commercial pilot for prostate 135 NHS trusts in England < 1% penetration cancer pathw
Slide 22: Execution of Oneview's growth strategy
Execution of Oneview’s growth strategy For personal use only Oneview has a clearly defined pathway to implementing its growth strategy 1H17 2H17 2018+ Significant contract Significant contract Expected signings with a major Expected major expansion with In-Patient signings (BJC, signing (University
Slide 23: Financial performance and KPIs
For personal use only Financial performance and KPIs 23
Slide 24: Key operating metrics
Key operating metrics For personal use only Oneview continues to see growth across key metrics Contracted bed & pipeline developments IPO Dec-16 Jun-17 Oct-17 Scheduled to be delivered in FY18 12,607 11,466 7,704 5,532 5,633 4,786 5,508 3,812 4,510 2,666 3,000 3,134 1,998 2,515 1,896 1,294 Beds Live
Slide 25: Tender Pipeline
Tender Pipeline For personal use only Oneview continues to receive an increasing number of inbound bid requests • Oneview continues to develop its pipeline across all of its geographies • Oneview has a high win rate with 67% of all bids submitted (based on bids submitted over 2016 and 2017) • Signif
Slide 26: Financial performance
Financial performance For personal use only Continued growth in recurring revenue base despite procurement inertia in recent periods • Oneview experienced procurement inertia by hospitals in FY16 and 1H17 Revenue (€m) o Healthcare policy uncertainty in US following Trump election caused slow down in
Slide 27: FY17 and pipeline update
FY17 and pipeline update For personal use only • High visibility of FY17 revenue of ~€6.6m • Improved market momentum in the United States following period of uncertainty • Significant investment in Android solution with phased deployment to existing US customers o Android solution expected to mater
Slide 28: For personal use only
Onéeview> Ajuo esn —— BUOSIGA LOY
Slide 29: Appendix A Pro Forma Balance Sheet
For personal use only Appendix A Pro Forma Balance Sheet 29
Slide 30: Pro forma balance sheet
Pro forma balance sheet For personal use only 30-Jun-17 30-Jun-17 Pro forma balance sheet € millions Impact of Offer1 Statutory Pro Forma converted to AUD1 Assets Cash and cash equivalents 22.6 18.8 41.5 61.6 • The Pro Forma Historical Balance Sheet is derived from the reviewed Trade and other recei
Slide 31: Appendix B Key Risks
For personal use only Appendix B Key Risks 31
Slide 32: Key Business Risks
Key Business Risks For personal use only Risk category Risk Risk description Strategy risks Failure to successfully There is a risk that Oneview’s business strategy or any of its growth initiatives will not be successfully implemented, deliver the expected returns or ultimately implement its busines
Slide 33: Key Business Risks
Key Business Risks For personal use only Risk category Risk Risk description Financial risks Reduced access to In the future, Oneview could be required to raise capital through public or private financing or other arrangements. Such financing may not be available on funding acceptable terms, or at a
Slide 34: Key Business Risks
Key Business Risks For personal use only Risk category Risk Risk description Operational risks Contract risk Oneview’s customer contract tender processes often take 12-18 months to materialise. As a consequence, there is a timing risk: external factors may change (cont.) the nature of these contract
Slide 35: Key Business Risks
Key Business Risks For personal use only Risk category Risk Risk description Operational risks Actual and potential Due to the contractual nature of Oneview’s relationships, Oneview may in the future be subject to claims, disputes or proceedings in its ordinary course of (cont.) disputes business. A
Slide 36: Key Business Risks
Key Business Risks For personal use only Risk category Risk Risk description Operational risks Intellectual property risk Oneview relies on its intellectual property rights and there is a risk that Oneview may fail to protect its rights for a number of reasons. Oneview has historically (cont.) used
Slide 37: Key Business Risks
Key Business Risks For personal use only Risk category Risk Risk description Operational risks Dependency on service Oneview conducts a significant amount of its operations through a series of contractual relationships with third party service providers. Such arrangements (cont.) providers carry a r
Slide 38: Key Transaction Risks
Key Transaction Risks For personal use only Risk category Risk Risk description Transaction risks Underwriting risk Oneview has entered into an underwriting agreement under which the lead manager and underwriter of the Entitlement Offer has agreed to fully underwrite the Offer, subject to the terms
Slide 39: Key Transaction Risks
Key Transaction Risks For personal use only Risk category Risk Risk description Transaction risks Risks associated with There are general risks associated with investments in equity capital such as Oneview CDIs. The trading price of Oneview CDIs may fluctuate with movements in (cont.) an investment
Slide 40: Appendix C Selling restrictions
For personal use only Appendix C Selling restrictions 40
Slide 41: International offer restrictions
International offer restrictions For personal use only This document does not constitute an offer of New CDIs of the Company in any jurisdiction in which it would be unlawful. In particular, this document may not be distributed to any person, and the New CDIs may not be offered or sold, in any count
Slide 42: International offer restrictions
International offer restrictions For personal use only Switzerland The New CDIs may not be publicly offered in Switzerland and will not be listed on the SIX Swiss Exchange or on any other stock exchange or regulated trading facility in Switzerland. This document has been prepared without regard to t
Slide 43: End
For personal use only Investor Presentation -End- 43
Oneview Healthcare — Investor Presentation (November 2017) on 6ix